Company / Assets per Share
Summit Therapeutics Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.00
FY2025
5-year range
$0.34 / $6.77
FY2021-FY2025
Trend
+61.8%
vs FY2024
Sector context
#201 of 210
Health Care
What the data says
Among 210 Health Care companies, Summit Therapeutics Inc. is in the bottom 4% for assets per share. Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $1.00.
Based on SEC 10-K filings.
1.00 in FY2025 with a 5-year CAGR of -8.0%.
Improved from $0.96 to $1.00 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -47.1%
- 5-Year CAGR
- -8.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 210This company $1.00 Sector average $353.15
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 61.8% year-over-year.
- Ranks #201 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.00 | +61.8% |
| FY2024 | $0.62 | -35.4% |
| FY2023 | $0.96 | -85.8% |
| FY2022 | $6.77 | +1908.7% |
| FY2021 | $0.34 | -77.9% |
| FY2020 | $1.53 | -48.0% |
| FY2019 | $2.93 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026